CURRENT TRENDS IN PRESCRIBING PATTERN OF ANTI-MIGRAINE DRUGS IN PATIENTS OF MIGRAINE AT A TERTIARY CARE TEACHING HOSPITAL

Authors

DOI:

https://doi.org/10.11603/ijmmr.2413-6077.2021.2.12636

Keywords:

DALY, MIDAS Score System, migraine, WHO Prescribing Indicators

Abstract

Background. An inappropriate prescribing pattern of antimigraine drugs by doctors may often encourage inappropriate self-medication by patients because of the asymmetry of medical information.

Objective. The study is aimed to assess the current trends in prescribing patterns of anti-migraine drugs, rationality of prescription, and pattern of migraine severity in patients of migraine.

Methods. A cross sectional study was conducted at a tertiary care teaching hospital. All the prescribing details including patient’s demographic details, diagnosis, details of drug therapy (drug name, dose, duration, and frequency) were recorded. Rationality of prescription was assessed using the WHO core drug prescribing indicators and the pattern of severity of migraine was assessed using MIDAS scoring system.

Results. Out of 85 patients, 71 were female (83.5%), mostly around 21-30 years of age, and 27 (31.7%) patients had other comorbidities. Naproxen was the most commonly used NSAID for termination of acute migraine attack (15.3 %). The most common drugs prescribed for prophylaxis included beta adrenergic blockers (Propranolol, 14.66%), antidepressants (Amitriptyline, 9.33% and Fluoxetine 3.33%), and antipsychotics (Prochlorperazine, 4.66%). Domperidone (17.30%) was the most commonly prescribed antiemetic. Prescription of triptans was low (2.66%) with Rizatriptan as the most commonly prescribed triptan.

Conclusions. The current study revealed that further improvements are required in prescribing practices especially in average number of drugs per prescription, prescription of drugs with generic names, and prescription of drugs of the essential drugs list.

Author Biographies

G. Soni, MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL, JAIPUR, INDIA

B.Sc. (Nursing), M.Sc (Medicine) Part-II Student, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur, India

S. Jain, MD (Pharmacology), Professor, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur, India

MD (Pharmacology), Professor, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur, India

P. Rathi, MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL, JAIPUR, INDIA

MD (Pharmacology), Professor, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur, India

 

P. Goswami, MAHATMA GANDHI MEDICAL COLLEGE AND HOSPITAL, JAIPUR, INDIA

MBBS, Second Year Post-graduate Resident, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur, India

References

Sumelahti ML, Mattila K, Sillanmaki L, Sumanen M. Prescription patterns in preventive and abortive migraine medication. Int. J headache Society. 2011;31(16):1659-63.

https://doi.org/10.1177/0333102411427602

Mukhopadhyay K, Joseph NE, Barkondaj B, Mukherjee S, Chatterjee C, Chakraborty S. A clinical study on prescribing features and prescription pat­tern for migraine in a tertiary care hospital of Eastern India. J of the Ind.Med Asso. 2020;118(4):23-26.

Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin. 2001;17(Suppl 1):S4-S12.

https://doi.org/10.1185/0300799039117005

Rozen TD, Swanson JW, Stang PE, McDonnell SK, Rocca WA. Increasing incidence of medically re­cognized migraine headache in a United States po­pu­lation. Neurology. 1999;53(7):1468- 73.

https://doi.org/10.1212/WNL.53.7.1468

D’Antona L, Matharu M. Identifying and mana­ging refractory Migraine: Barriers and Opportunities? The J of Headache and Pain. 2019;20(1):79-89.

https://doi.org/10.1186/s10194-019-1040-x

Goadsy PJ, Schoenen J, Ferrari MD, Silber­stein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Int. J Cephalgia. 2006;26(9):1168-70.

https://doi.org/10.1111/j.1468-2982. 2006.01173.x

Silberstein SD, Dodick DW, Pearlman S. Defining the pharmacologically intractable headache for clinical trials and clinical practice. Int. J of Headache. 2010;50(9):1499-1506.

https://doi.org/10.1111/j.1526-4610.2010. 01764.x

Emily Shao, James Hughes, Rob Eley. The presenting and prescribing patterns of migraine in an Australian emergency department: A descriptive exploratory study. World J Emerg Med. 2017;8(3): 170-76.

https://doi.org/10.5847/wjem.j.1920-8642. 2017.03.002

FMHACA. Manual for Medicines Good Prescribing Practice. Addis Ababa: Food, Medicine and Healthcare Administration and Control Authority of Ethiopia; 2012. Available from: http://apps.who.int/medicinedocs/documents/s22353en/s22353en.pdf.

Shankar R, Partha P, Shenoy N. Prescribing patterns of drugs among patients admitted with cardiovascular disorders in the internal medicine ward: Prescribing patterns in inpatients. Internet J Pharmacol. 2001;1(2).

https://doi.org/10.5580/18a7

Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa University teaching and referral hospital, South Ethiopia: A cross-sectional study: BMC Health Services Res. 2013;13:170. Available at http://www.biomedcentral.com/1472-6963/13/170.

https://doi.org/10.1186/1472-6963-13-170

Wang H, Li N, Zhu H, Xu S, Lu H, Feng Z. Prescription pattern and its influencing factors in Chinese county hospitals: A retrospective cross-sectional study. PLoS One. 2013;8(5):e63225.

https://doi.org/10.1371/journal.pone.0063225

Jawed S, Ali W, Yaqoob U, Shah S, Uddin SMM, Haq A. Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Asses­sment Score: A Cross-Sectional Study. Pain Ther. 2019;8(2):233-38. doi:10.1007/s40122-019-0130-4.

https://doi.org/10.1007/s40122-019-0130-4

van de Ven RC, Kaja S, Plomp JJ, Frants, RR, van den Maagdenberg AMJM, Ferrari MD. Genetic models of migraine. Arch Neurol. 2007;64:643-46.

https://doi.org/10.1001/archneur.64.5.643

Kamran Khan, Mudassar Iqbal Arain, Muhammad Ali Ghoto, Abdullah Dayo, Mehrukh Zehravi, Ahad Abdul Rehman. Prescribing trends of antimigraine drugs amongst general physicians and neuro physicians in southern Pakistan: A comparative approach. Isra Med J. 2019;11(4): 275-80.

Huda Kafeel, Ramsha Rukh. Prevalence of headache in general population of Karachi, Pakistan. J App Pharm. 2017; 6:308 -13.

Aravamuthan A, Arputhavanan M, Subra­maniam K, Sam Johnson Udaya Chander J. Assessment of current prescribing practices using World Health Organization core drug use and complementary indicators in selected rural community pharmacies in Southern India. J of Pharm Policy and Pract. 2017;10(1).

https://doi.org/10.1186/s40545-016-0074-6

Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Natl Med J India. 2000;13(4):177-82.

Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at Hawassa Uni­versity teaching and referral hospital, south Ethiopia: A cross-sectional study. BMC Health Services Res. 2013;13:170. Available at http://www.biomedcentral.com/1472-6963/13/170.

https://doi.org/10.1186/1472-6963-13-170

Downloads

Published

2022-04-18

How to Cite

Soni, G., Jain, S., Rathi, P., & Goswami, P. (2022). CURRENT TRENDS IN PRESCRIBING PATTERN OF ANTI-MIGRAINE DRUGS IN PATIENTS OF MIGRAINE AT A TERTIARY CARE TEACHING HOSPITAL. International Journal of Medicine and Medical Research, 7(2), 5–14. https://doi.org/10.11603/ijmmr.2413-6077.2021.2.12636